Drug profile · INN
valrubicin
VALSTAR PRESERVATIVE FREE
valrubicin (VALSTAR PRESERVATIVE FREE) is a dna topoisomerase ii alpha inhibitor. Route of administration: intravesical. Current US regulatory status: approved.
Drug details — valrubicin
- US status
- approved
- Class
- —
- Route
- INTRAVESICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
valrubicin (VALSTAR PRESERVATIVE FREE) is a dna topoisomerase ii alpha inhibitor. Route of administration: intravesical. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA topoisomerase II alpha inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is valrubicin?
valrubicin (VALSTAR PRESERVATIVE FREE) is a dna topoisomerase ii alpha inhibitor. Route of administration: intravesical. Current US regulatory status: approved.
What is the brand name for valrubicin?
VALSTAR PRESERVATIVE FREE is a marketed brand name for valrubicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of valrubicin?
valrubicin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.